F. J. Mackay

803 total citations
13 papers, 610 citations indexed

About

F. J. Mackay is a scholar working on Pharmacology, Psychiatry and Mental health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, F. J. Mackay has authored 13 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 6 papers in Psychiatry and Mental health and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in F. J. Mackay's work include Treatment of Major Depression (5 papers), Schizophrenia research and treatment (5 papers) and Electroconvulsive Therapy Studies (3 papers). F. J. Mackay is often cited by papers focused on Treatment of Major Depression (5 papers), Schizophrenia research and treatment (5 papers) and Electroconvulsive Therapy Studies (3 papers). F. J. Mackay collaborates with scholars based in United Kingdom. F. J. Mackay's co-authors include Ronald D. Mann, L. V. Wilton, Nicholas Dunn, Shayne N. Freemantle, G. L. Pearce, Richard M. Martin, Gillian Pearce, Lynda V. Wilton, N. Ray Dunn and Kate Macintyre and has published in prestigious journals such as Epilepsia, BMC Public Health and BJOG An International Journal of Obstetrics & Gynaecology.

In The Last Decade

F. J. Mackay

13 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. J. Mackay United Kingdom	10	247	200	145	127	100	13	610
Shayne N. Freemantle United Kingdom	14	212 0.9×	144 0.7×	170 1.2×	93 0.7×	98 1.0×	22	778
Paul B. van den Berg Netherlands	19	219 0.9×	81 0.4×	291 2.0×	264 2.1×	66 0.7×	43	981
Jean‐Pierre Blayac France	16	106 0.4×	99 0.5×	104 0.7×	72 0.6×	51 0.5×	50	749
Dylan M. Zylla United States	15	270 1.1×	184 0.9×	135 0.9×	113 0.9×	62 0.6×	34	806
Michael G. O’Neil United States	9	101 0.4×	66 0.3×	69 0.5×	104 0.8×	22 0.2×	15	592
David Lussier Canada	12	63 0.3×	191 1.0×	149 1.0×	161 1.3×	61 0.6×	25	642
Diego Macías Saint-Gerons Spain	14	303 1.2×	45 0.2×	48 0.3×	86 0.7×	107 1.1×	46	751
Christopher W. Goodman United States	6	61 0.2×	94 0.5×	116 0.8×	175 1.4×	51 0.5×	11	500
S. Welch Canada	8	86 0.3×	72 0.4×	61 0.4×	144 1.1×	174 1.7×	10	724
Douglas J. Hsu United States	14	576 2.3×	133 0.7×	85 0.6×	147 1.2×	21 0.2×	26	894

Countries citing papers authored by F. J. Mackay

Since Specialization

Citations

This map shows the geographic impact of F. J. Mackay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. J. Mackay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. J. Mackay more than expected).

Fields of papers citing papers by F. J. Mackay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. J. Mackay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. J. Mackay. The network helps show where F. J. Mackay may publish in the future.

Co-authorship network of co-authors of F. J. Mackay

This figure shows the co-authorship network connecting the top 25 collaborators of F. J. Mackay. A scholar is included among the top collaborators of F. J. Mackay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. J. Mackay. F. J. Mackay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Shaw, Rebecca, Michelle Gillies, Heather Sloan, et al.. (2010). Overcoming barriers to engaging socio-economically disadvantaged populations in CHD primary prevention: a qualitative study. BMC Public Health. 10(1). 391–391. 61 indexed citations

2.

Mackay, F. J., G. L. Pearce, Shayne N. Freemantle, & Ronald D. Mann. (1999). Nefazodone in community use: the results of prescription-event monitoring. Pharmacoepidemiology and Drug Safety. 8(4). 267–273. 4 indexed citations

3.

Mackay, F. J., et al.. (1999). Losartan: a study of pharmacovigilance data on 14 522 patients. Journal of Human Hypertension. 13(8). 551–557. 19 indexed citations

4.

Mackay, F. J., Nicholas Dunn, & Ronald D. Mann. (1999). Antidepressants and the serotonin syndrome in general practice.. PubMed. 49(448). 871–4. 134 indexed citations

5.

Mackay, F. J.. (1998). Post-Marketing Studies. Drug Safety. 19(5). 343–353. 19 indexed citations

6.

Mackay, F. J., L. V. Wilton, G. L. Pearce, Shayne N. Freemantle, & Ronald D. Mann. (1998). United Kingdom experience with alendronate and oesophageal reactions.. PubMed. 48(429). 1161–2. 22 indexed citations

7.

Mackay, F. J., L. V. Wilton, G. L. Pearce, Shayne N. Freemantle, & Ronald D. Mann. (1998). The safety of risperidone: a post-marketing study on 7684 patients. Human Psychopharmacology Clinical and Experimental. 13(6). 413–418. 24 indexed citations

8.

Wilton, L. V., G. L. Pearce, Richard M. Martin, F. J. Mackay, & Ronald D. Mann. (1998). The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. BJOG An International Journal of Obstetrics & Gynaecology. 105(8). 882–889. 103 indexed citations

9.

Mackay, F. J., Nicholas Dunn, Lynda V. Wilton, et al.. (1997). A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies. Pharmacoepidemiology and Drug Safety. 6(4). 235–246. 74 indexed citations

10.

Mackay, F. J., et al.. (1997). Safety of Long‐Term Lamotrigine in Epilepsy. Epilepsia. 38(8). 881–886. 112 indexed citations

11.

Mann, Ronald D., L. V. Wilton, G. L. Pearce, F. J. Mackay, & N. Ray Dunn. (1997). Prescription‐event monitoring (PEM) in 1996—a method of non‐interventional observational cohort pharmacovigilance. Pharmacoepidemiology and Drug Safety. 6(S3). S5–S11. 7 indexed citations

12.

Mann, Ronald D., L. V. Wilton, G. L. Pearce, F. J. Mackay, & N. Ray Dunn. (1997). Prescription-event monitoring (PEM) in 1996-a method of non-interventional observational cohort pharmacovigilance.. PubMed. 6 Suppl 3. S5–11. 26 indexed citations

13.

Mackay, F. J., Nicholas Dunn, Lynda V. Wilton, et al.. (1997). A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies. Pharmacoepidemiology and Drug Safety. 6(4). 235–246. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact